Saturday 17 October 2026 Export DRIO’s income statement to Excel — free account

DarioHealth Corp.

DRIO Healthcare Health Information Services

DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.58%, EPS grew 76.4%, free cash flow was flat and total debt rose 1.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.95 0.18 −3.51%

Follow DRIO

Alert me

Market cap: $50.3M
P/E: 0.0×
Fwd P/E: −1.9×
Dividend yield: —
F-score: 3/9
Altman Z: −5.72
Beneish M: −3.58
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.10

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	1	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 17.59%

Capital & Financial Ratios $m

Market Cap 50.27

Revenue 21.00

Net Income (35.67)

Free Cash Flow (25.47)

Net Debt 16.81

Current Ratio 2.31

Debt/Equity 0.56

P/E ratio 0.00

Fwd P/E (1.90)

P/S ratio 2.20

P/B ratio 0.84

Past 5Y EPS Growth —

This Y EPS Growth 60.70%

Next Y EPS Growth 36.63%

Next Y revenue growth (2.14%)

Next 5Y EPS Growth 45.15%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 54.04%

10-year low 10-year high

P/B against its own 10 years 57.75%

10-year low 10-year high

EV/Sales against its own 10 years 64.40%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	37	29	26	14
Receivables	5	7	5	4
Inventory	5	5	4	4
Other	—	—	—	—
	47	41	35	22

	2023	2024	2025	Q'26
Payables	1	3	3	3
ST’ Debt	4	5	—	—
Other	—	—	—	—
	12	17	9	10

Compound Annual Growth %

	10y	5y	3y
Sales	39.13%	24.17%	(6.84%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	56.37%	19.26%	(5.31%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	6	5	—	—	—
’25	7	5	5	5	22
’24	6	6	7	8	27
’23	7	6	4	4	20
’22	8	6	7	7	28
’21	4	5	6	6	21
’20	2	2	2	2	8

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(6)	(6)	—	—	—
’25	(7)	(6)	(7)	(6)	(26)
’24	(13)	(11)	(7)	(7)	(39)
’23	(5)	(10)	(9)	(7)	(30)
’22	(18)	(11)	(11)	(8)	(48)
’21	(11)	(12)	(12)	(15)	(50)
’20	(5)	(3)	(4)	(7)	(18)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(6)	(6)	—	—	—
’25	(7)	(6)	(7)	(6)	(26)
’24	(13)	(11)	(7)	(7)	(39)
’23	(5)	(10)	(9)	(7)	(31)
’22	(18)	(11)	(11)	(8)	(48)
’21	(11)	(12)	(13)	(15)	(51)
’20	(5)	(3)	(4)	(7)	(18)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	(2.80)	(3.60)	—	(1.07)	—
’24	(4.00)	(6.83)	(5.00)	(1.80)	(17.43)
’23	(9.30)	(11.60)	(9.80)	(9.90)	(38.60)
’22	(14.80)	(14.80)	(12.80)	(10.20)	(50.80)
’21	(18.40)	(19.80)	(23.60)	(21.80)	(81.40)
’20	(64.01)	(13.60)	(17.88)	(21.20)	(98.76)

Fiscal quarters ending in the months shown.

value withheld pending a data check

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	53.42	26.60	13.12	4.00	60.40	200.40	70.60	13.60	12.62	5.94	Analyst estimates 2026–2028 Powerpack
	High	3,491.97	94.00	43.00	225.00	449.80	637.00	274.20	135.60	52.00	31.00
People
People	Employees	31	48	76	72	139	214	252	294	202	165
	Revenue/emp, $m	0.09	0.11	0.10	0.10	0.05	0.10	0.11	0.07	0.13	0.14
Income, $m
Income, $m	Revenue	3	5	7	8	8	21	28	20	27	22
	Gross margin, %	(29.61)	25.36	23.87	34.36	33.17	19.32	34.91	29.40	49.06	56.64
	EBT	(11)	(16)	(18)	(18)	(29)	(77)	(62)	(59)	(45)	(42)
	EBT margin, %	(388.41)	(304.51)	(240.78)	(234.63)	(388.66)	(374.05)	(224.87)	(291.68)	(164.94)	(186.10)
	Net income	(11)	(16)	(18)	(18)	(29)	(77)	(62)	(59)	(43)	(42)
	Depreciation	0	0	0	0	0	4	5	5	7	3
Per share, $
Per share, $	Revenue	215.62	214.52	126.18	66.72	25.41	24.73	23.40	14.35	11.03	5.61
	Earnings	(836.00)	(656.00)	(312.00)	(160.00)	(98.76)	(81.40)	(50.80)	(38.60)	(17.43)	(10.12)
	Cash flow	(644.54)	(440.62)	(195.73)	(138.79)	(59.48)	(60.76)	(40.48)	(21.41)	(15.73)	(6.51)
	Capex	(62.15)	(8.09)	(1.21)	(0.86)	(0.40)	(0.31)	(0.48)	(0.41)	(0.06)	(0.04)
	Free cash flow	(706.69)	(448.71)	(196.95)	(139.66)	(59.87)	(61.08)	(40.97)	(21.83)	(15.78)	(6.55)
	Book value	(503.15)	163.53	152.30	166.76	94.40	103.12	67.69	40.99	29.37	17.05
	Shares, m	0	0	0	0	0	1	1	1	2	4
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	0.29	0.15	0.12	1.97	11.25	10.49	3.72	2.36	1.43	2.03
	P/B	0.00	0.20	0.10	0.79	3.03	2.52	1.29	0.82	0.54	0.67
	EV/Sales	(0.18)	(0.62)	(1.39)	(0.65)	7.52	8.75	2.90	1.94	1.44	2.69
	EV/FCF	0.05	0.29	0.89	0.31	(3.19)	(3.54)	(1.65)	(1.26)	(0.99)	(2.27)
Cash, $m
Cash, $m	Operating cash flow	(8)	(11)	(11)	(16)	(18)	(50)	(48)	(30)	(39)	(26)
	Capex	(1)	0	0	0	0	0	(1)	(1)	0	0
	Free cash flow	(9)	(11)	(12)	(16)	(18)	(51)	(48)	(31)	(39)	(26)
Balance, $m
Balance, $m	Working capital	0	3	8	18	27	31	46	35	24	26
	Total debt	—	—	—	1	1	0	27	29	29	31
	Net debt	(1)	(4)	(11)	(20)	(28)	(36)	(23)	(9)	0	5
	Shareholders’ equity	(7)	4	9	19	28	86	80	58	72	68
Returns, %
Returns, %	ROA	(259.40)	(295.47)	(173.87)	(108.08)	(110.39)	(115.68)	(58.04)	(58.92)	(38.07)	(53.93)
	ROIC	0.00	0.00	0.00	0.00	0.00	(95.93)	(61.85)	(70.80)	(49.91)	(31.63)
	ROE	285.85	1,230.62	(284.41)	(150.19)	(140.73)	(138.55)	(77.12)	(91.95)	(62.97)	(88.23)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
OPRX OptimizeRx Corp.	$166.7M	35.4×	23.0×	−29.77% (below 0%: shrinking)	n/m	+89.86% (above 0%: growing)	76.51%	(0.43%)	Compare
DH Definitive Healthcare Corp.	$144.3M	— (loss-making)	— (loss-making)	−9.14% (below 0%: shrinking)	n/m	+21.44% (above 0%: growing)	73.45%	(12.23%)	Compare
HCAT Health Catalyst, Inc.	$135.5M	— (loss-making)	— (loss-making)	−12.68% (below 0%: shrinking)	n/m	+64.26% (above 0%: growing)	49.46%	(51.75%)	Compare
LFMD LifeMD, Inc.	$118.6M	— (loss-making)	— (loss-making)	−3.55% (below 0%: shrinking)	n/m	−247.52% (below 0%: shrinking)	88.82%	(15.08%)	Compare
CCLD CareCloud, Inc.	$82.0M	26.4×	12.5×	+16.45% (above 0%: growing)	n/m	+6.15% (above 0%: growing)	45.24%	5.84%	Compare
DRIO DarioHealth Corp.	$50.3M	— (loss-making)	— (loss-making)	−3.58% (below 0%: shrinking)	n/m	−0.74% (below 0%: shrinking)	61.66%	(125.15%)
ONMD OneMedNet Corporation	$28.6M	— (loss-making)	—	+88.39% (above 0%: growing)	n/m	+14.05% (above 0%: growing)	(193.49%)	(774.32%)	Compare
BEAT HeartBeam, Inc.	$24.3M	— (loss-making)	—	—	n/m	−1.24% (below 0%: shrinking)	—	0.00%	Compare
RNLXY Renalytix plc - Sponsored ADR	$17.2M	— (loss-making)	—	+13.73% (above 0%: growing)	n/m	+17.96% (above 0%: growing)	19.16%	(783.91%)	Compare
Median of peers	$100.3M	—	—	−3.55%	—	+16.01%	49.46%	(13.65%)

All 51 Health Information Services stocks →